Mutation analysis of tumor tissue revealed BRAF V600E/K mutation in 16 (64%), NRAS mutation in 2 (8%) and GNAQ or GNA11 mutation in 4 (n = 2, 8%; uveal melanoma; n = 2, 8%, primary CNS melanoma) patients. This evidence concerns the gene NRAS and primary melanoma of the central nervous system.